MENU
TELO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Telomir Pharmaceuticals (TELO) Ownership - Who owns Telomir Pharmaceuticals?
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science... Show more
Profile
Industry
N/A
Address
855 N Wolfe Street
Phone
+1 737 289-0835
Employees
9
Web
https://www.telomirpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
48.15M
P/E Ratio
N/A
Total Cash
403K
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TELO
Capitalization
48.1M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
403K
Total Cash/Share
0.01
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-161.11K
P/B Ratio
116.28
Cash Flow
N/A
Earnings
-0.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
0.75
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-12.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-623.78
Shares Held By Institutions
18.6M
Shares Outstanding - Current
30.9M
Total Liabilities
652K
Total Volume MTD
N/A
Value
-1
Gain YTD
-62.136
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TELO showed earnings on May 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
855 N Wolfe Street
Phone
+1 737 289-0835
Employees
9
Web
https://www.telomirpharma.com